Warfarin testing company raises funds
Microvisk Technologies, developer of a handheld device to monitor blood clotting in patients taking the drug warfarin, has secured £2.5 million.
News
Microvisk Technologies, developer of a handheld device to monitor blood clotting in patients taking the drug warfarin, has secured £2.5 million.
News
News
News
News
Partner content
Accounting and Finance Software
Accounting and Finance Software